Search Results - Ibrahim H.
- Showing 1 - 20 results of 229
- Go to Next Page
-
1
Agency costs,corporate governance mechanisms and performance of public listed family firms in Malaysia by Ibrahim, H., Abdul Samad, F.
Published 2007Get full text
Get full text
Conference or Workshop Item -
2
Investigation into an indigenous fermented milk food. by Ibrahim, H. Ahmad
Get full text
Get full text
Conference or Workshop Item -
3
Establishment of cell and root suspension cultures from curcuma xanthorhiza for the production of xanthorhizol by Mohamed, M., Ibrahim, H., Annuar, M.S.M., Khalid, N.
Published 2007Get full text
Get full text
Conference or Workshop Item -
4
Production of zerumbone from in vitro derived rhizome of zingiber zerumbet. for pharmaceutical and cosmeceutical industry by Idris, F.D., Khalid, N., Ibrahim, H., Annuar, M.S.M.
Published 2007Get full text
Get full text
Conference or Workshop Item -
5
Down-regulation of miR-210 enhances sensitivity towards 1'S-1'-acetoxychavicol acetate (ACA) in human cervical carcinoma cells by Hun, P.N., Nurul Azmi, M., Ibrahim, H., Awang, Khalijah, Nagoor, N.H.
Published 2014Get full text
Get full text
Conference or Workshop Item -
6
-
7
Continued improvement and normalization of myocardial T2*in patients with beta-thalassemia major treated with deferasirox (Exjade (R)) for up to 3 years by Pennell, D., Porter, J.B., Cappellini, M.D., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, Chi-Kong, Viprakasit, V., Elalfy, M.S., Kattamis, A., Smith, G., Habr, D., Domokos, G., Roubert, B., Taher, A.
Published 2010Get full text
Article -
8
Continued improvement in cardiac T2*with deferasirox treatment over 2 years: Results from the extension of epic cardiac substudy in beta-thalassaemia patients with myocardial sider... by Pennell, D., Porter, J., Cappellini, M., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M., Kattamis, A., Smith, G., Habr, D., Roubert, B., Taher, A.
Published 2010Get full text
Article -
9
Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone t... by Pennell, D., Porter, J., Cappellini, M., Chan, L.L., El-Beshlawy, A., Aydinok, Y., Ibrahim, H., Li, C.K., Viprakasit, V., Elalfy, M., Kattamis, A., Smith, G., Habr, D., Roubert, B., Taher, A.
Published 2010Get full text
Article -
10
-
11
-
12
Family business in emerging markets: The case of Malaysia by Ibrahim, H., Samad, F.A.
Published 2010Get full text
Article -
13
Establishment of tissue culture for selected medicinal curcuma spp by Yusuf, N.A., Khalid, Norzulaani, Ibrahim, H.
Published 2007Get full text
Get full text
Article -
14
-
15
-
16
-
17
-
18
-
19
-
20
